US Stock MarketDetailed Quotes

TSHA Taysha Gene Therapies

Watchlist
  • 2.4450
  • +0.2650+12.16%
Trading Nov 22 14:40 ET
501.09MMarket Cap3.88P/E (TTM)

Taysha Gene Therapies Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2024/Q3
Stock NameRevenueRatio
Business of developing AAV-based gene therapies for the treatment of rare monogenic diseases of the1.79M100.00%
Region Currency:USD
2023/FY
Stock NameRevenueRatio
United States15.45M100.00%

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data